EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

NYSE:ESRT • US2921041065

5.775 USD
+0.04 (+0.61%)
Last: Mar 3, 2026, 03:06 PM
Fundamental Rating

4

ESRT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. ESRT has only an average score on both its financial health and profitability. ESRT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ESRT was profitable.
  • In the past year ESRT had a positive cash flow from operations.
  • Of the past 5 years ESRT 4 years were profitable.
  • Of the past 5 years ESRT 4 years had a positive operating cash flow.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • With a Return On Assets value of 0.85%, ESRT perfoms like the industry average, outperforming 52.46% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 3.25%, ESRT is in line with its industry, outperforming 57.38% of the companies in the same industry.
  • ESRT's Return On Invested Capital of 2.87% is in line compared to the rest of the industry. ESRT outperforms 54.92% of its industry peers.
  • ESRT had an Average Return On Invested Capital over the past 3 years of 2.75%. This is in line with the industry average of 3.09%.
  • The last Return On Invested Capital (2.87%) for ESRT is above the 3 year average (2.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROIC 2.87%
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)3.89%
ROE(5y)2.87%
ROIC(3y)2.75%
ROIC(5y)2.48%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4

1.3 Margins

  • ESRT has a Profit Margin of 4.55%. This is comparable to the rest of the industry: ESRT outperforms 52.46% of its industry peers.
  • ESRT's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.68%, ESRT is in line with its industry, outperforming 44.26% of the companies in the same industry.
  • ESRT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ESRT (54.04%) is worse than 74.59% of its industry peers.
  • In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ESRT is destroying value.
  • ESRT has more shares outstanding than it did 1 year ago.
  • ESRT has less shares outstanding than it did 5 years ago.
  • ESRT has a better debt/assets ratio than last year.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.56, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
  • ESRT has a Altman-Z score of 0.56. This is comparable to the rest of the industry: ESRT outperforms 52.46% of its industry peers.
  • ESRT has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • ESRT's Debt to Equity ratio of 1.92 is on the low side compared to the rest of the industry. ESRT is outperformed by 68.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.49
WACC5.89%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.59 indicates that ESRT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 2.59, ESRT belongs to the best of the industry, outperforming 95.08% of the companies in the same industry.
  • ESRT has a Quick Ratio of 2.59. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.59, ESRT belongs to the top of the industry, outperforming 95.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

4

3. Growth

3.1 Past

  • ESRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.10%, which is quite impressive.
  • ESRT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 57.42% yearly.
  • Looking at the last year, ESRT shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
  • The Revenue has been growing slightly by 4.75% on average over the past years.
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%

3.2 Future

  • Based on estimates for the next years, ESRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -39.35% on average per year.
  • The Revenue is expected to grow by 2.24% on average over the next years.
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.64, the valuation of ESRT can be described as very cheap.
  • ESRT's Price/Earnings ratio is rather cheap when compared to the industry. ESRT is cheaper than 95.08% of the companies in the same industry.
  • ESRT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.13.
  • With a Price/Forward Earnings ratio of 94.36, ESRT can be considered very expensive at the moment.
  • ESRT's Price/Forward Earnings is on the same level as the industry average.
  • ESRT is valuated expensively when we compare the Price/Forward Earnings ratio to 28.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.64
Fwd PE 94.36
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaply inside the industry as 93.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.66
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • ESRT's earnings are expected to decrease with -61.15% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%

3

5. Dividend

5.1 Amount

  • ESRT has a Yearly Dividend Yield of 2.31%.
  • With a Dividend Yield of 2.31, ESRT pays less dividend than the industry average, which is at 7.15. 84.43% of the companies listed in the same industry pay a better dividend than ESRT!
  • ESRT's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.31%

5.2 History

  • The dividend of ESRT decreases each year by -17.38%.
  • ESRT has paid a dividend for at least 10 years, which is a reliable track record.
  • ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • 79.65% of the earnings are spent on dividend by ESRT. This is not a sustainable payout ratio.
  • The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP79.65%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (3/3/2026, 3:06:04 PM)

5.775

+0.04 (+0.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners100.46%
Inst Owner Change1.31%
Ins Owners0.08%
Ins Owner Change0%
Market Cap982.85M
Revenue(TTM)768.27M
Net Income(TTM)34.89M
Analysts75
Price Target7.51 (30.04%)
Short Float %4.27%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield 2.31%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP79.65%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.54%
PT rev (3m)-16.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.64
Fwd PE 94.36
P/S 1.28
P/FCF N/A
P/OCF 3.71
P/B 0.92
P/tB 3.58
EV/EBITDA 8.66
EPS(TTM)0.87
EY15.06%
EPS(NY)0.06
Fwd EY1.06%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)1.56
OCFY26.98%
SpS4.5
BVpS6.31
TBVpS1.61
PEG (NY)N/A
PEG (5Y)0.12
Graham Number11.11
Profitability
Industry RankSector Rank
ROA 0.85%
ROE 3.25%
ROCE 3.64%
ROIC 2.87%
ROICexc 2.99%
ROICexgc 3.79%
OM 18.68%
PM (TTM) 4.55%
GM 54.04%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.76%
ROE(3y)3.89%
ROE(5y)2.87%
ROIC(3y)2.75%
ROIC(5y)2.48%
ROICexc(3y)2.96%
ROICexc(5y)2.68%
ROICexgc(3y)3.73%
ROICexgc(5y)3.4%
ROCE(3y)3.48%
ROCE(5y)3.14%
ROICexgc growth 3Y-2.22%
ROICexgc growth 5Y10.35%
ROICexc growth 3Y-1.13%
ROICexc growth 5Y11.75%
OM growth 3Y0.36%
OM growth 5Y10.63%
PM growth 3Y4.1%
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF N/A
Debt/EBITDA 6.18
Cap/Depr 140.72%
Cap/Sales 34.79%
Interest Coverage 1.49
Cash Conversion 79.7%
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 0.56
F-Score6
WACC5.89%
ROIC/WACC0.49
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.1%
EPS 3Y34.2%
EPS 5Y57.42%
EPS Q2Q%-4.17%
EPS Next Y-92.97%
EPS Next 2Y-75.79%
EPS Next 3Y-61.15%
EPS Next 5Y-39.35%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y1.86%
Revenue growth 5Y4.75%
Sales Q2Q%2.96%
Revenue Next Year2.89%
Revenue Next 2Y2.2%
Revenue Next 3Y1.81%
Revenue Next 5Y2.24%
EBIT growth 1Y-8.53%
EBIT growth 3Y2.22%
EBIT growth 5Y15.89%
EBIT Next Year144.54%
EBIT Next 3Y36.3%
EBIT Next 5Y22.27%
FCF growth 1Y98.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.21%
OCF growth 3YN/A
OCF growth 5YN/A

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status for ESRT stock?

ChartMill assigns a valuation rating of 4 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Fairly Valued.


What is the profitability of ESRT stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 5 / 10.


What is the valuation of EMPIRE STATE REALTY TRUST-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EMPIRE STATE REALTY TRUST-A (ESRT) is 6.64 and the Price/Book (PB) ratio is 0.92.


What is the financial health of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.